Skip to main navigation Skip to search Skip to main content

A Phase II Multicenter Randomized Study to Determine the Optimal Dose of Isovue-370 for MDCTA in Patients Suspected of Coronary Artery Disease (CAD)

Project: Research

Project Details

StatusFinished
Effective start/end date05/13/0903/11/11

Funding

  • Bracco Diagnostics Incorporated: $7,137.50